Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2017; 7(1): 007-016


Anti-inflammatory action of seed extract and polymeric nanoparticles of Syzygium cumini in diabetic rats infected with Candida albicans

Paula E. R. Bitencourt, Lariane O. Cargnelutti, Carolina S Stein, Raquel Lautenchleger, Luana M. Ferreira, Manuela Sangoi, Aline Boligon, Marta M. M. F. Duarte, Rafael N. Moresco, Letícia Cruz, Régis A. Zanette, Sydney H. Alves, Maria Beatriz Moretto.

Abstract
The involvement of ectonucleotidases during infections has been described for several microorganisms and the purines are recognized for their important role in modulating processes linked to inflammation. However, there is little information on how these enzymes would contribute to the understanding of pathological condition in fungal infections in DM. We demonstrate that aqueous seed extract of S. cumini (ASc) and polymeric nanoparticles containing ASc (NPASc), despite having low antifungal action, showed great anti-inflammatory activity as observed by the decrease in the activity of enzymes related to purinergic system (5'NT, NTPDase, ADA and DPP-IV) and in the release of molecules involved in the immune / inflammatory system (nitric oxide, interleukin-1, IL-6, TNF-α and IFN-ɣ).
The present study demonstrates that purinergic and immunologic systems are unbalanced in this model of DM and C. albicans infection and the modulation of ectoenzyme activities can be one of the mechanisms by which S. cumini act on cytokines that affect the development of chronic complications of DM

Key words: Diabetes model; Candida albicans infection; cytokines; ectonucleotidases; Syzygium cumini seeds; nanotechnology.



Share this Article


Advertisement
Journal of Complementary Medicine Research

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.